Skip to content

Group News

Judy Dlamini, Aspen Chairman’s Upper Echelon interview

Aug 8, 2012

“I actually want to work until the very last day of my life”, Judy Dlamini ALEC HOGG: Upper Echelon is brought to you by Deloitte – for innovative thinking and thorough strategic planning turn to Deloitte. In our Upper Echelon this week, Judy Dlamini, chair of Mbekani Investment Holdings and better known through her chair…

Read More >>

Aspen businesses activate 29 Mandela Day projects globally

Jul 16, 2012

Durban: Aspen, one of the world’s top 10 generic pharmaceutical companies by revenue and the largest pharmaceutical manufacturer in the southern hemisphere, is activating 29 projects across 11 countries on 6 continents in celebration of 2012 Nelson Mandela International Day (“Mandela Day”). Stephen Saad, Aspen Group Chief Executive said, “We have embraced Mandela Day across…

Read More >>

Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages

Jun 20, 2012

Johannesburg – over the past days and weeks, there have been widespread reports from various State Clinics, in certain provinces, that patients have been unable to access supplies of TDF, a key ARV, used primarily in first line HIV treatment. Due to the negative consequences on both patients and the sustainability of South Africa’s Public…

Read More >>

To rest is to rust : Financial Mail Wonderful Weekend

Jun 7, 2012

In my youth I imagined that I would be a professional sportsman or a game ranger. It hasn’t turned out that way, but I don’t have any regrets about the choices I have made. I believe you have to take advantage of the opportunities that are presented to you and adapt if and when necessary.…

Read More >>

30 000 ARV packs delivered in Limpopo

Jun 1, 2012

Following discussions between the health Minister Dr Aaron Motsoaledi and Aspen Pharmacare Senior Executive Mr Stavros Nicolaou in Johannesburg, Aspen Pharmacare released 30 000 packs of Tenofovir (TDF) for the Limpopo depot earlier today. Further releases to this province are expected during the course of next week. Aspen Pharmacare is one of the two (2)…

Read More >>

Statement by Aspen on the reported Tenofovir (TDF) public sector supply shortages

May 31, 2012

Statement by Aspen on the reported Tenofovir (TDF) public sector supply shortages Johannesburg: Since March this year there have been sporadic reports of Tenofovir (TDF) supply shortages in certain provinces and hospitals where patients are receiving ARV treatment. These reports seem to have manifested again this week and some allegations have emerged that the contracted…

Read More >>

Stephen Saad raises R10 million for children

May 7, 2012

Health Minister supports Stephen Saad’s initiative as he raises R10m for children Durban: Health Minister Dr Aaron Motsoaledi’s support of the Sifiso Nxasana Paediatric Trust for the Children of Africa (“the Trust”), which is raising funds for paediatric hospitals, is paying off with R10 million already raised. The campaign was recently launched by pharmaceutical entrepreneur…

Read More >>

Stephen Saad completes grueling 240km mountain bike challenge

Apr 29, 2012

Stephen Saad completes grueling Aspen Trans Karoo challenge Sutherland, Western Cape: Stephen Saad, Aspen Group Chief Executive, completed the grueling inaugural 240km Aspen Trans Karoo mountain bike challenge in 15hrs59min30sec in a bid to raise funds for desperately needed paediatric healthcare facilities in South Africa. Raynard Tissink won the endurance race in a time of…

Read More >>

Stephen Saad & Health Minister cycle for children’s hospitals

Apr 28, 2012

Ceres, Western Cape: Health Minister Dr Aaron Motsoaledi and Stephen Saad, Aspen Group Chief Executive started the grueling inaugural 240km Aspen Trans Karoo mountain bike challenge together earlier today to enhance healthcare for children in South Africa. Stephen said, “Raising funds for paediatric healthcare facilities through the Sifiso Nxasana Paediatric Trust for the Children of…

Read More >>

Aspen announces multi-territory acquisition of GSK OTC products for R2.1 billion

Apr 20, 2012

Aspen Pharmacare Holdings Limited (“Aspen”) (Incorporated in the Republic of South Africa) Registration Number 1985/002935/06 Share code APN – ISIN: ZAE000066692 (“Aspen Holdings”) ASPEN ANNOUNCES MULTI-TERRITORY ACQUISITION OF GSK OTC PRODUCTS FOR R2.1 BILLION Durban, South Africa: Aspen Holdings is pleased to announce that the Aspen Group (“Aspen”) has reached agreement with GlaxoSmithKline plc (“GSK”)…

Read More >>

MEDIA ENQUIRIES

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Scroll To Top